Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01703507||Active, not recruiting||Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma||
||Other / Industry||
||24||All||18 Years and older (Adult, Senior)||NCT01703507||12P.314
|November 9, 2012||May 20, 2015||November 2019||October 10, 2012||December 11, 2017||